Considering the different mechanisms of action and limitations discussed for AuroLase® (AuNP PTT) and NanoTherm® (IONP MHT), which factor represents the intrinsic advantage of the MHT approach for treating deeply located brain tumours (like glioblastoma)?

Question

Considering the different mechanisms of action and limitations discussed for AuroLase® (AuNP PTT) and NanoTherm® (IONP MHT), which factor represents the  intrinsic  advantage  of the MHT approach for treating deeply located brain tumours (like glioblastoma)?

Answer

The stronger Localized Surface Plasmon Resonance (LSPR) effect of IONPs compared to AuNPs.

Answer

The deep and uniform penetration of the activating Alternating Magnetic Field (AMF) through the skull and brain tissue.

Answer

The ability to trigger drug release simultaneously using the magnetic field.

Answer

The higher biodegradability of iron oxide compared to gold.

Crowdly

Considering the different mechanisms of action and limitations discussed for Aur...

Want instant access to all verified answers on learning.monash.edu?